Epidermal necrolysis after COVID-19 vaccination: An exploratory analysis using World Health Organization VigiBase

J Eur Acad Dermatol Venereol. 2023 Apr;37(4):e456-e459. doi: 10.1111/jdv.18845. Epub 2023 Jan 20.

Btisseme Ahouach¹, Emmanuelle Diaz¹, Blandine Bertin², Benoit Ben Said^{3

4}, Sandrine Combret⁵, Aurélie Grandvuillemin⁵, Nadine Petitpain⁶, Marie Blanche Rabier⁷, Laure Thomas⁸, Thierry Trenque⁹, Saskia Ingen-Housz-Oro^{1

4

10}, Bénédicte Lebrun-Vignes^{4

10

11}

¹ Dermatology Department, Henri-Mondor Hospital AP-HP, Créteil, France.
² Pharmacovigilance Center, Hospital University Pharmacotoxicology Department, Hospices Civils de Lyon HCL, Lyon, France.
³ Dermatology Department, Edouard Herriot Hospital, Lyon, France.
⁴ Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil, France.
⁵ Pharmacovigilance Department, Dijon University Hospital, Dijon, France.
⁶ Pharmacovigilance Department, Nancy-Brabois Hospital, Vandoeuvre-lès-Nancy, France.
⁷ Pharmacovigilance Department, Besançon University Hospital, Besançon, France.
⁸ Pharmacovigilance Department, Henri-Mondor Hospital AP-HP, Créteil, France.
⁹ Pharmacovigilance Department, University Hospitals of Reims, Reims, France.
¹⁰ Univ Paris Est Créteil Epiderme, UPEC, Créteil, France.
¹¹ Pharmacovigilance Department, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.

No abstract available

Publication types